There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.

Biologics Quality Control: The Growing Need for Accessible Proteomics

The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.

Emerging Therapies Drive Analytical Advancements

Effective analytics will eliminate failures, deviations, and non-conformances.

 Analyzing Exabytes

Topic

Articles

Also, NicOx and DSM make manufacture and supply pact for naproxcinod drug substance; NovaRx appointed Norrie Russell president and COO; more...

Company and People Notes: BMS and AstraZeneca Expand Collaboration; Johnathan Knowles to Retire from Roche in 2009; More...

A Centers for Disease Control and Prevention (CDC) study confirmed that severe adverse reactions reported in the fall and winter of 2007 resulted from heparin contaminated with oversulfated chondroitin sulfate (OSCS).

CDC Identifies Cause of Heparin-Related Reactions

Also, AstraZeneca announces changes to its supply chain operations; Christian Velmer appointed head of Wyeth Canada; More...

Company and People Notes: Lilly Completes Acquisition of ImClone; Novocell CEO to Lead The Juvenile Diabetes Research Foundation; More...

Mohamed Etman is a professor of pharmaceutics at the Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.

Hala Nada is the R&D manager at the European Egyptian Company for Pharmaceuticals, Alexandria, Egypt.

Aly Nada is an associate professor and chairman at the Department of Pharmaceutics, Faculty of Pharmacy, Kuwait University, PO Box 24923 Safat, 13110 Kuwait, tel. 00965 4986072, fax: 00965 4986843, 

Fatma Ismail is a professor at the Faculty of Pharmacy, Alexandria University.

Mamdouh Moustafa is a professor and consultant at Arab Company for Drug Industries and Medical Appliances (ACDIMA), Cairo, Egypt.

Said Khalil is a professor at the Faculty of Pharmacy, Alexandria University.

The authors evaluated the effect of polymer composition on the drug-release profile and the effect of storage conditions on dissolution characteristics.

Formulation of Sustained-Release Ketorolac Tromethamine Pellets

The past year saw major acquisitions attempted, completed, rejected, and stalled.

Billion-Dollar Deals of 2008

Readers provide insight into the best companies to work for as well as the ups and downs of their jobs.

The Good, the Bad, and the Best Jobs

Michelle Hoffman, editorial director of Pharmaceutical Technology.

China's quality approach to domestic versus exported products seems to be a lose-lose situation.

A Tale of Two Pharmaceutical Industries

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

A recent Pharmaceutical Technology survey examined the level, sources, and reasons behind innovation in drug development and manufacturing. This article contains bonus online-exclusive material.

Gauging Innovation in Pharmaceutical Development and Manufacturing

Sanjay Garg, PhD, is an associate professor at the School of Pharmacy, University of Auckland, Auckland, New Zealand, and a member of the Pharmaceutical Technology Editorial Advisory Board.

A book about pharmaceutical analysis engages the reader with history and unexpected asides.

A Peak in Mass-Spectrometry Literature

Graham T. Illing, PhD, is a CMC director and group manager of global regulatory affairs at AstraZeneca (Macclesfield, England). 

Robert J. Timko, PhD, is a CMC director of global regulatory affairs at AstraZeneca LP, 1800 Concord Pike, PO Box 15437, Wilmington, DE 19850-5437, tel. 302.886.2164, fax 302.886.1557, robert.timko@astrazeneca.com

Linda Billett is a CMC director of global regulatory affairs at AstraZeneca (Macclesfield).

The authors review the current regulatory framework for the selection of drug substance starting materials.

Analytics

Biologics Quality Control: The Growing Need for Accessible Proteomics

Emerging Therapies Drive Analytical Advancements

Analyzing Exabytes